{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:58:10Z","timestamp":1760889490758},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAPES\/Brazil","award":["5639-10-7"],"award-info":[{"award-number":["5639-10-7"]}]},{"name":"Department of Pharmaceutics, University of Florida"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ijantimicag.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T03:45:22Z","timestamp":1507952722000},"page":"190-196","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dermal pharmacokinetics of pyrazinamide determined by microdialysis sampling in rats"],"prefix":"10.1016","volume":"51","author":[{"given":"Nivea M.F.","family":"Voelkner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Voelkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherwin K.B.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0010","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","volume":"281","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0015","series-title":"Manual de vigil\u00e2ncia da Leishmaniose Tegumentar Americana [Manual of surveillance of American Cutaneous Leishmaniasis]","author":"Brazilian Ministry of Health, Secretariat of Health Surveillance","year":"2010"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0020","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0025","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1128\/AAC.01146-09","article-title":"The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells","volume":"53","author":"Mendez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nm0698-655","article-title":"The next frontier of molecular medicine: delivery of therapeutics","volume":"4","author":"Jain","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1055\/s-0032-1315262","article-title":"Dermal pharmacokinetics of terpinen-4-ol following topical administration of Zingiber cassumunar (plai) oil","volume":"78","author":"Chooluck","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.coph.2005.04.010","article-title":"Microdialysis for in vivo pharmacokinetic\/pharmacodynamics characterization of anti-infective drugs","volume":"5","author":"Brunner","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0045","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.3390\/molecules15128567","article-title":"Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated n-phenylpyrazine-2-carboxamides","volume":"15","author":"Dolezal","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.22.9.686.34067","article-title":"Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis","volume":"22","author":"Zhu","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bmj.294.6567.284","article-title":"Penetration of pyrazinamide into the cerebrospinal fluid in tuberculosis meningitis","volume":"294","author":"Ellard","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.107.014894","article-title":"Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats","volume":"35","author":"Wu","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0160-5402(91)90021-V","article-title":"A comparison between three methods for estimation of extracellular concentration of exogenous and endogenous compounds by microdialysis","volume":"25","author":"Stahle","year":"1991","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0070","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.41.12.2670","article-title":"Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide","volume":"41","author":"Peloquin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0075","author":"US Food and Drug Administration"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0080","series-title":"Handbook of non-invasive methods and the skin","first-page":"443","article-title":"Microdialysis methodology for sampling in the skin","author":"Groth","year":"2006"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0085","series-title":"NONMEM users guide. (1989\u20132010)","author":"Beal","year":"2010"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0090","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2011"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","article-title":"Perl-speaks-NONMEM (PsN)\u2014a Perl module for NONMEM related programming","volume":"75","author":"Lindbom","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","article-title":"Pira\u00f1a and PCluster: a modeling environment and cluster infrastructure for NONMEM","volume":"101","author":"Keizer","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0009-9120(95)02024-1","article-title":"In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and \u03b1-1-acid glycoprotein","volume":"29","author":"Woo","year":"1996","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0140-6736(90)91945-7","article-title":"Recurrent lesions in human Leishmania braziliensis infection\u2014reactivation or reinfection?","volume":"336","author":"Saravia","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/322643","article-title":"Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment","volume":"33","author":"Marovich","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0166-6851(84)90137-3","article-title":"Identification of species, strains and clones of Leishmania by characterization of kinetoplast DNA minicircles","volume":"12","author":"Spithill","year":"1984","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1201-9712(00)90078-X","article-title":"Treatment of visceral leishmaniasis (kala azar): a decade of progress and future approaches","volume":"4","author":"Murray","year":"2000","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-4362.2000.00687.x","article-title":"Leishmaniasis recidiva cutis","volume":"39","author":"Cannavo","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0035-9203(86)90243-9","article-title":"Mucosal leishmaniasis (\u2018espundia\u2019 Escomel, 1911)","volume":"80","author":"Marsden","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-4632.2004.02518.x","article-title":"Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization","volume":"45","author":"Calvopina","year":"2006","journal-title":"Int Soc Dermatol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/rvsc.1999.0361","article-title":"Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs","volume":"68","author":"Lindecrona","year":"2000","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2885.2010.01223.x","article-title":"Plasma and tissue pharmacokinetics of danofloxacin in healthy and in experimentally infected chickens with Pasteurella multocida","volume":"34","author":"Zeng","year":"2011","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1080\/19440049.2015.1078915","article-title":"Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae","volume":"32","author":"Bladek","year":"2015","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0165","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-3083.1987.tb02308.x","article-title":"Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences","volume":"26","author":"Akuffo","year":"1987","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00034983.1969.11686649","article-title":"Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands","volume":"63","author":"Lemma","year":"1969","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.ijantimicag.2017.10.001_bib0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2012.00163","article-title":"FasL and TRAIL signaling in the skin during cutaneous leishmaniasis\u2014implications for tissue immunopathology and infectious control","volume":"3","author":"Rethi","year":"2012","journal-title":"Front Immunol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T13:18:02Z","timestamp":1582550282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917303655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0924857917303655"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermal pharmacokinetics of pyrazinamide determined by microdialysis sampling in rats","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}